Abigél Margit Kolonics-Farkas

Author

Also Known As

A. Kolonics-Farkas, A. M. Kolonics-Farkas, Abigel Kolonics-Farkas, Abigel Kolonics‐Farkas, Abigel M. Kolonics-Farkas, Abigel M. Kolonics‐Farkas, Abigel Margit Kolonics-Farkas, Abigél M. Kolonics-Farkas, Abigél Margit Kolonics-Farkas

Publications

122

Citations

H-Index

Concepts

All Affiliations

Semmelweis University Charles University Masaryk University University Hospital Dubrava Comenius University Bratislava

About

Abigél Margit Kolonics-Farkas is an author at Semmelweis University specializing in pulmonary disease, medicine, and pulmonary fibrosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	26
2	Pulmonary Disease	1	1	26
3	Pulmonary Medicine	1	1	26
4	Pulmonary Fibrosis	1	1	26
5	Antifibrotic Therapy	1	1	26

Abigél Margit Kolonics-Farkas

Publications

113

Citations

H-Index

Page 1

	Year	Citations
Long-Term Effects and Adverse Events of Nintedanib Therapy in Idiopathic Pulmonary Fibrosis Patients with Functionally Advanced Disease Enikő Bárczi, Livia Starobinski, Abigél Margit Kolonics-Farkas, Advances in Therapy Nintedanib TherapyAdverse EventsAntifibrotic TherapyLong-term EffectsAdvanced Lung Disease	2019	26
Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival Enikő Bárczi, Tamás Nagy, Livia Starobinski, Thoracic Cancer	2020	23
Anticoagulant Use and Bleeding Risk in Central European Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Antifibrotic Therapy: Real-World Data from EMPIRE Abigél Margit Kolonics-Farkas, Martina Šterclová, Nesrin Moğulkoç, Drug Safety	2020	20
Autoimmune Progressive Fibrosing Interstitial Lung Disease: Predictors of Fast Decline Alexandra Nagy, Tamás Nagy, Abigél Margit Kolonics-Farkas, Frontiers in Pharmacology	2021	18
Differences in Baseline Characteristics and Access to Treatment of Newly Diagnosed Patients With IPF in the EMPIRE Countries Abigél Margit Kolonics-Farkas, Martina Šterclová, Nesrin Moğulkoç, Frontiers in Medicine	2021	14
Worse lung cancer outcome in patients with lower respiratory tract infection confirmed at time of diagnosis Attila Nagy, Veronika Müller, Abigél Margit Kolonics-Farkas, Thoracic Cancer	2019	12

Page 1